Financials Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Equities
002603
CNE1000015S0
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.91 CNY | -0.07% |
|
-4.20% | -13.12% |
Projected Income Statement: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 8,736 | 10,117 | 12,533 | 10,318 | 6,513 | 10,283 | 11,329 | 12,410 |
| Change | - | 15.81% | 23.88% | -17.67% | -36.88% | 57.89% | 10.18% | 9.53% |
| EBITDA 1 | 1,713 | 1,939 | 3,271 | 2,321 | -0.422 | 1,325 | 1,502 | 1,668 |
| Change | - | 13.18% | 68.7% | -29.03% | -100.02% | 314,030.54% | 13.37% | 11.06% |
| EBIT 1 | 1,438 | 1,569 | 2,830 | 1,780 | -688.9 | 1,425 | 1,643 | 1,846 |
| Change | - | 9.15% | 80.33% | -37.1% | -138.71% | 306.88% | 15.32% | 12.32% |
| Interest Paid | 1.338 | -17.32 | -19.92 | -26.37 | -22.41 | - | - | - |
| Earnings before Tax (EBT) 1 | 1,423 | 1,554 | 2,781 | 1,684 | -800.2 | 1,381 | 1,609 | 1,827 |
| Change | - | 9.22% | 78.97% | -39.43% | -147.51% | 272.59% | 16.52% | 13.53% |
| Net income 1 | 1,220 | 1,344 | 2,362 | 1,352 | -724.5 | 1,215 | 1,737 | 1,607 |
| Change | - | 10.15% | 75.75% | -42.74% | -153.57% | 267.71% | 42.95% | -7.46% |
| Announcement Date | 2/25/21 | 4/28/22 | 4/25/23 | 4/26/24 | 4/28/25 | - | - | - |
1CNY in Million
Estimates
Forecast Balance Sheet: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | -1,048 | 466 | -845 | -1,453 | -2,477 | -3,310 |
| Change | - | - | - | 144.47% | -281.33% | -71.99% | -70.47% | -33.63% |
| Announcement Date | 2/25/21 | 4/28/22 | 4/25/23 | 4/26/24 | 4/28/25 | - | - | - |
1CNY in Million
Estimates
Cash Flow Forecast: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 1,144 | 672.4 | 213.6 | 309.9 | 290.4 | 534.4 | 590.8 | 652 |
| Change | - | -41.25% | -68.23% | 45.05% | -6.29% | 84.05% | 10.54% | 10.36% |
| Free Cash Flow (FCF) 1 | 441.7 | - | - | - | - | - | - | - |
| Change | - | - | - | - | - | - | - | - |
| Announcement Date | 2/25/21 | 4/28/22 | 4/25/23 | 4/26/24 | 4/28/25 | - | - | - |
1CNY in Million
Estimates
Forecast Financial Ratios: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
| EBITDA Margin (%) | 19.61% | 19.16% | 26.1% | 22.5% | -0.01% | 12.88% | 13.26% | 13.44% |
| EBIT Margin (%) | 16.46% | 15.51% | 22.58% | 17.25% | -10.58% | 13.86% | 14.51% | 14.87% |
| EBT Margin (%) | 16.28% | 15.36% | 22.19% | 16.32% | -12.29% | 13.43% | 14.2% | 14.72% |
| Net margin (%) | 13.97% | 13.28% | 18.84% | 13.11% | -11.12% | 11.82% | 15.33% | 12.95% |
| FCF margin (%) | 5.06% | - | - | - | - | - | - | - |
| FCF / Net Income (%) | 36.2% | - | - | - | - | - | - | - |
Profitability | ||||||||
| ROA | 11.8% | 11.02% | 15.89% | 7.96% | -4.78% | 8.93% | 9.48% | 9.76% |
| ROE | 14.45% | 14.94% | 23.62% | 12.16% | -6.69% | 10.93% | 12.73% | 11.67% |
Financial Health | ||||||||
| Leverage (Debt/EBITDA) | - | - | - | 0.2x | - | - | - | - |
| Debt / Free cash flow | - | - | - | - | - | - | - | - |
Capital Intensity | ||||||||
| CAPEX / Current Assets (%) | 13.1% | 6.65% | 1.7% | 3% | 4.46% | 5.2% | 5.21% | 5.25% |
| CAPEX / EBITDA (%) | 66.81% | 34.68% | 6.53% | 13.35% | -68,809.88% | 40.34% | 39.34% | 39.09% |
| CAPEX / FCF (%) | 259.11% | - | - | - | - | - | - | - |
Items per share | ||||||||
| Cash flow per share 1 | 0.9412 | 0.3164 | 2.088 | 0.093 | 0.3657 | 0.6 | 1.23 | 1.37 |
| Change | - | -66.38% | 559.8% | -95.55% | 293.23% | 64.07% | 105% | 11.38% |
| Dividend per Share 1 | 0.7143 | 0.3 | 0.5 | 0.3 | - | 0.2265 | 0.2641 | 0.2976 |
| Change | - | -58% | 66.67% | -40% | - | - | 16.61% | 12.7% |
| Book Value Per Share 1 | 5.336 | 5.428 | 6.544 | 6.853 | 6.119 | 6.848 | 7.582 | 8.41 |
| Change | - | 1.74% | 20.54% | 4.73% | -10.71% | 11.92% | 10.72% | 10.92% |
| EPS 1 | 0.7286 | 0.8044 | 1.414 | 0.8095 | -0.4337 | 0.7286 | 1.038 | 0.9602 |
| Change | - | 10.41% | 75.75% | -42.74% | -153.58% | 267.99% | 42.5% | -7.51% |
| Nbr of stocks (in thousands) | 1,667,081 | 1,670,705 | 1,670,705 | 1,670,705 | 1,670,705 | 1,670,705 | 1,670,705 | 1,670,705 |
| Announcement Date | 2/25/21 | 4/28/22 | 4/25/23 | 4/26/24 | 4/28/25 | - | - | - |
1CNY
Estimates
| 2025 * | 2026 * | |
|---|---|---|
| P/E ratio | 19.1x | 13.4x |
| PBR | 2.03x | 1.83x |
| EV / Sales | 2.12x | 1.83x |
| Yield | 1.63% | 1.9% |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.91CNY
Average target price
15.38CNY
Spread / Average Target
+10.57%
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002603 Stock
- Financials Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition